CTCBIO Inc Capital Reinvestment Ratio
CTCBIO Inc capital reinvestment ratio. CTCBIO Inc (060590) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩5.64 Billion) in capital expenditures (₩212.02 Million). Check total reinvestment intensity of CTCBIO Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of CTCBIO Inc (2013–2024)
Capital reinvestment ratio of CTCBIO Inc from 2013 to 2024. This chart tracks CTCBIO Inc's Capital Reinvestment Ratio across 10 annual periods. Also explore net asset growth rate of CTCBIO Inc to track the company's year-over-year net asset growth rate.
CTCBIO Inc Capital Reinvestment Ratio by Year (2013–2024)
CTCBIO Inc capital reinvestment ratio by year from 2013 to 2024. For the full cash flow conversion analysis, see CTCBIO Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | ₩4.50 Billion | ₩2.14 Billion | ▲ +107.4% |
| 2023 | 0.23x | ₩8.22 Billion | ₩1.88 Billion | ▲ +31.8% |
| 2022 | 0.17x | ₩18.22 Billion | ₩3.17 Billion | ▼ -32.8% |
| 2021 | 0.26x | ₩6.46 Billion | ₩1.67 Billion | ▼ -93.1% |
| 2020 | 3.77x | ₩510.09 Million | ₩1.92 Billion | ▲ +185.2% |
| 2019 | 1.32x | ₩1.68 Billion | ₩2.22 Billion | ▼ -90.0% |
| 2017 | 13.22x | ₩295.30 Million | ₩3.90 Billion | ▲ +573.9% |
| 2016 | 1.96x | ₩6.86 Billion | ₩13.46 Billion | ▼ -88.1% |
| 2015 | 16.50x | ₩1.44 Billion | ₩23.71 Billion | ▲ +647.6% |
| 2013 | 2.21x | ₩2.74 Billion | ₩6.05 Billion | — |